A migraine pill which could change the lives of thousands of people who suffer from the 'incredibly debilitating' condition should be made accessible on the NHS 'swiftly', a charity has said. Atogepant - sold under the brand name Aquipta and made by AbbVie - has been given the green light for NHS use under new final draft guidance from the National Institute for Health and Care Excellence .
Read more on Sky News: Xylazine: Powerful 'zombie drug' known as Tranq has 'penetrated' UK market, experts warnBridget Jones is back: Zellweger will star in fourth film - but a key love interest won't return 'We now need to ensure access is swift, so that migraine patients can benefit from them as quickly as possible.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: